SFDA Showcases Smart Technologies and Interactive Experiences at LEAP25

The Saudi Food and Drug Authority (SFDA) is showcasing advanced smart technologies and interactive experiences at LEAP25, held in Riyadh under the slogan ‘Into New Worlds,’ from February 9 to 12, 2025. The SFDA’s participation highlights its commitment to leveraging digital innovation to enhance product safety, improve medicine accessibility, and raise public awareness about its regulatory work.

Context and Background

LEAP25 is a premier global technology conference that brings together innovators, investors, and policymakers to explore emerging technologies and their impact on various sectors. The SFDA’s involvement aligns with Saudi Arabia’s Vision 2030, which prioritizes digital transformation and the adoption of smart solutions to improve public health and regulatory efficiency.

Key Details

At the SFDA pavilion, visitors can explore advanced digital systems used in monitoring and regulating food, pharmaceuticals, medical devices, and supplies. Among the featured services is a drug alternatives service that enables users to easily search for substitute medications, and a restricted drug possession service that ensures compliance with regulatory requirements. Smart moving screens display real-time statistics on inspection, licensing, and registration processes, offering an interactive experience for attendees.

Implications and Impact

These innovations demonstrate the SFDA’s leadership in adopting cutting-edge technologies to enhance regulatory oversight and public health protection. By showcasing these tools at an international platform like LEAP25, the SFDA positions itself as a forward-thinking authority committed to transparency and efficiency, while also attracting potential partnerships and investments in Saudi Arabia’s growing digital health ecosystem.

Vision 2030 Alignment

The SFDA’s participation at LEAP25 underscores the Kingdom’s dedication to achieving the goals of Vision 2030, particularly in building a vibrant society with a high quality of life through digital innovation and robust regulatory frameworks. As Saudi Arabia continues to transform into a global hub for technology and innovation, the SFDA’s smart solutions will play a critical role in safeguarding public health and supporting the nation’s economic diversification.

20 Questions

Q1. What is the Saudi Food and Drug Authority (SFDA)?

A1. The SFDA is the regulatory body responsible for ensuring the safety and quality of food, drugs, medical devices, and supplies in Saudi Arabia. It sets standards and monitors compliance.

Q2. What is LEAP25?

A2. LEAP25 is a major international technology conference held in Riyadh, Saudi Arabia, under the slogan ‘Into New Worlds,’ focusing on digital innovation and emerging technologies across various sectors.

Q3. When and where is LEAP25 taking place?

A3. LEAP25 is taking place in Riyadh from February 9 to 12, 2025, bringing together global tech leaders, innovators, and investors to explore new technologies.

Q4. Why is the SFDA participating in LEAP25?

A4. The SFDA participates to showcase its smart technologies and digital solutions aimed at enhancing product safety, improving medicine accessibility, and raising public awareness about its regulatory work.

Q5. What technologies is the SFDA showcasing at LEAP25?

A5. The SFDA is showcasing advanced digital systems for monitoring food, pharmaceuticals, medical devices, and supplies, including smart moving screens with real-time statistics.

Q6. What is the drug alternatives service?

A6. The drug alternatives service is a digital tool that allows users to easily search for substitute medications, helping patients and healthcare providers find alternative drugs.

Q7. What is the restricted drug possession service?

A7. The restricted drug possession service is a digital solution that ensures compliance with regulatory requirements for handling restricted medications, promoting safe and legal use.

Q8. How do the smart moving screens work?

A8. The smart moving screens display real-time data on inspection, licensing, and registration processes, offering an interactive and informative experience for conference attendees.

Q9. What is the goal of SFDA’s participation in LEAP25?

A9. The goal is to highlight the SFDA’s commitment to digital transformation and innovation in regulatory oversight, while engaging with international experts and potential partners.

Q10. How does LEAP25 align with Vision 2030?

A10. LEAP25 supports Vision 2030 by promoting innovation, digital transformation, and economic diversification, particularly in sectors like health technology and smart regulation.

Q11. What is the SFDA’s role in public health?

A11. The SFDA ensures the safety, efficacy, and quality of food, drugs, and medical products, protecting public health and supporting the healthcare system in Saudi Arabia.

Q12. How does the SFDA use digital technology?

A12. The SFDA uses digital technology for monitoring, inspection, licensing, and public services, including online platforms for reporting and searching for information.

Q13. Can the public use the drug alternatives service?

A13. Yes, the drug alternatives service is designed for public use, enabling patients and healthcare providers to quickly find substitute medications when needed.

Q14. What is the significance of real-time statistics?

A14. Real-time statistics improve transparency and efficiency, allowing the SFDA to track regulatory processes and share up-to-date information with stakeholders.

Q15. How does the SFDA ensure compliance?

A15. The SFDA enforces compliance through inspections, licensing requirements, and digital tools like the restricted drug possession service that track and verify adherence to regulations.

Q16. What other innovations does the SFDA have?

A16. The SFDA continually develops digital solutions for food safety monitoring, drug registration, and medical device oversight, often piloting new technologies at events like LEAP.

Q17. How does LEAP25 benefit Saudi Arabia?

A17. LEAP25 positions Saudi Arabia as a regional hub for technology and innovation, attracting investment, fostering partnerships, and showcasing the Kingdom’s progress in digital transformation.

Q18. Who can attend the SFDA pavilion at LEAP25?

A18. The SFDA pavilion is open to all LEAP25 attendees, including industry professionals, investors, government officials, and the general public interested in health regulation technology.

Q19. What is the SFDA’s future vision?

A19. The SFDA aims to become a global leader in regulatory science and digital oversight, using advanced technologies to protect public health and support Saudi Arabia’s healthcare goals.

Q20. How can I get more information about SFDA’s services?

A20. More information is available on the SFDA’s official website and through its digital platforms, which offer resources on regulations, services, and public awareness campaigns.

---